| Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). | |
| | |
MedLine Citation:
|
PMID: 10588785 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We analyzed transesophageal echocardiograms from 772 participants in the Stroke Prevention in Atrial Fibrillation (SPAF-III) study, characterizing spontaneous echocardiographic contrast (SEC) in the left atrium or appendage as faint or dense. The association of dense SEC with stroke risk factors and anatomic, hemodynamic, and hemostatic parameters related to specific thromboembolic mechanisms was evaluated by multivariate analysis. Spontaneous echocardiographic contrast was present in 55% of patients and was dense in 13%. Age (odds ratio [OR] 2.4/decade, P <.001), constant atrial fibrillation (OR 6.9, P <.001), history of hypertension (OR 3. 2, P <.001), and current tobacco smoking (OR 2.6, P =.04) were independent clinical predictors of dense SEC. Multivariate analysis of clinical, echocardiographic, and hemostatic parameters yielded age as the sole independent clinical predictor of dense SEC (OR 2. 4/decade, P <.001). Other independent predictors were measures of left atrial/appendage flow dynamics, left atrial size (OR 2.4/cm diameter, M-mode, P <.001), atherosclerotic aortic plaque (OR 2.8, P =.002), and plasma fibrinogen >350 mg/dL (P <.001). Results were similar when SEC of any density was analyzed. In conclusion, SEC occurred in more than half of these patients with prospectively defined nonvalvular atrial fibrillation but was usually faint. Dense SEC was strongly associated with previously reported clinical predictors of stroke, linking them to thromboembolism through atrial stasis. Diverse pathophysiologic factors including atrial stasis, fibrinogen level, and aortic plaque influence SEC. |
| | |
Authors:
|
R W Asinger; J Koehler; L A Pearce; M Zabalgoitia; J L Blackshear; P E Fenster; R Strauss; D Hess; G D Pennock; R M Rothbart; J L Halperin |
Related Documents
:
|
15908245 - Intravenous amiodarone treatment in horses with chronic atrial fibrillation. 9164885 - Atrial fibrillation follow-up investigation of rhythm management -- the affirm study de... 18156545 - Pre-excited atrial fibrillation triggered by intravenous adenosine: a commonly used dru... 11776095 - The effect of transient balloon occlusion of the mitral valve on left atrial appendage ... 7375995 - Histoplasma capsulatum endocarditis requiring aortic valve replacement for aortic insuf... 11085825 - Conditioned nutritional requirements and the pathogenesis and treatment of myocardial f... |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography Volume: 12 ISSN: 0894-7317 ISO Abbreviation: J Am Soc Echocardiogr Publication Date: 1999 Dec |
Date Detail:
|
Created Date: 2000-01-05 Completed Date: 2000-01-05 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8801388 Medline TA: J Am Soc Echocardiogr Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1088-96 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, Hennepin County Medical Center, Minneapolis, MN 55415, USA. asing001@maroon.tc.mn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anticoagulants / therapeutic use Aspirin / therapeutic use Atrial Fibrillation / complications, physiopathology, ultrasonography* Blood Flow Velocity Contrast Media / administration & dosage Drug Therapy, Combination Echocardiography, Doppler Echocardiography, Transesophageal / methods* Female Humans Injections, Intravenous Intracranial Embolism and Thrombosis / etiology, physiopathology*, prevention & control Male Platelet Aggregation Inhibitors / therapeutic use Risk Factors Stroke / etiology, physiopathology, prevention & control* Warfarin / therapeutic use |
| Grant Support | |
ID/Acronym/Agency:
|
R01-NS-24224/NS/NINDS NIH HHS; R01-NS-33551/NS/NINDS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Contrast Media; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 81-81-2/Warfarin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow v...
Next Document: When the body and appendage of the left atrium disagree: "Focal" atrial fibrillation-implications fo...